As the world faces a mental health crisis, a panel at HBI 2023 discussed the impact telehealth and digital therapeutics have on the sector. But with growing demand and a lack of capacity, to what extent can a crisis of global proportions be tackled?
Oncology has come a long way in just a few decades to the point where cancer care is increasingly understood as a chronic condition, but more capacity is still needed. At HBI 2023, oncology panelists debated where the best opportunities for growth in the sector lie. Here were some of the takeaways:
Despite the uncertainty around regulatory reform, there are still significant opportunities in the German outpatient market, according to speakers on the ‘Investing in DACH’ panel at HBI 2023. Dentistry, which isn’t subject to the same regulatory restrictions as other outpatient specialities, presents a particularly big opportunity.
US-based healthcare real estate investment company Flagler Healthcare Investments is eyeing up opportunities in the big five European markets. Undeterred by high levels of regulation and hyper fragmentation, the German market is of particular interest.
Our annual conference took place earlier this week in London. Over a jam-packed three days of HBI 2023, an impressive array of delegates from across Europe and beyond gathered in the heart of London and shared their insights into the myriad challenges and abundant opportunities the sector faces, and offered their views on how some of them might be addressed. Here are some of our key takeaways.
Last week HBI reported on the South African parliament approving a national / statutory health insurance scheme, which would bring universal healthcare to the rainbow nation at the expense of private providers. HBI speaks to a South African operator to find out how this may affect them.
A glut of small outpatient clinics in Germany are coming to market as uncertainty grows over the nature of the reforms which federal Minister for Health Karl Lauterbach may be able to pass - but there are questions about the limits of Lauterbach's power.
M&A in European health care has been almost at a standstill in H1 2023, as the chasm between the price expectations of buyers and sellers has grown. HBI asks if the prospects look better for H2 and beyond, with the help of market experts.
The private healthcare markets in major Indian and middle eastern cities are on the brink of becoming mature according to a consulting source, and this will require operators and investors to take a different approach.
We look at how to build a dynamic, low-cost outpatient chain which delivers high quality care and at the UK venous market more generally with Jason Powell, whose UK Vein Clinic Group looks set to grow revenue 50% in 2024, after doubling sales in 2023.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.